Delivery Order SPE2DR25D2005-SPE2DR26FE6R3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials on September 10, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,286.87 and has an ultimate completion date of September 11, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $2,673.00 delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The vaccine will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Imovax Rabies Vaccine Vials at a firm fixed price of $25,113. This non-competitive delivery order is set to be completed by November 6, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,682.50 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine Vials, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, awarded on August 19, 2025, represents a non-competitive award under an existing contract vehicle. The vaccine will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply requirements, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $33,412.50 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed-price contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a competitively awarded, non-set-aside procurement with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $33,900.30 delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials on June 5, 2025, with an ultimate completion date of June 6, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,895.75 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. The contract, which was competitively awarded with no set-aside designation, is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,796.51 delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials, with a completion date of July 3, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials with a ceiling value of $10,023.75. This firm fixed-price delivery order, issued on September 26, 2025, is set to conclude by September 29, 2025, and will be fulfilled at the company's Conshohocken, Pennsylvania headquarters. The contract represents a competitive award with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMOVAX Rabies Vaccine Vials with a ceiling value of $12,591.13 under a firm fixed-price contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award was made without a set-aside designation, indicating it was competitively awarded. The delivery order...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6R3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of IMOVAX Rabies Vaccine Vials, with a contract ceiling value of $5,391.25 and an ultimate completion date of November 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026, which authorizes the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in meeting federal medical procurement requirements through its extensive portfolio of delivery orders with the Defense Logistics Agency. The company's federal contract awards span a wide range of pharmaceutical products including vaccines, specialty medications, and medical supplies across multiple therapeutic domains, serving defense health system customers including the Defense Health Agency and U.S. Coast Guard. This specific vaccine delivery order exemplifies the company's role as a critical vendor within the DLA's medical supply chain infrastructure, supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 11/12/25 |